Treatment of human B-NHL cell lines with an anti-Hsp110 antibody had no direct effect on cell cycle or apoptosis, but significantly reduced the tumor burden in xenotransplanted immunodeficient mice (63). Here, HSPH1 is linked to neoplasm.